Barclays Upgrades Onyx Pharmaceuticals (ONXX) to Overweight
Tweet Send to a FriendGet Alerts ONXX Hot Sheet
Price: $95.65 +0.31%
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
20 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade ONXX Now!
Barclays upgraded Onyx Pharmaceuticals (NASDAQ: ONXX) from Equalweight to Overweight with a price target of $85.00.
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $68.40 yesterday, with a 52 week range of $27.17-$68.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Onyx Pharmaceuticals click here. For more ratings news on Onyx Pharmaceuticals click here.
Shares of Onyx Pharmaceuticals closed at $68.40 yesterday, with a 52 week range of $27.17-$68.98.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
- Wells Fargo Upgrades Rosetta Resources (ROSE) to Outperform, Shares Attractive
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
Create E-mail Alert Related Categories
UpgradesRelated Entities
Barclays
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
